ALISA STRESSMAN: Open Payments
NPI 1235729534 · NORTON SHORES, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,783 in 69 payments from 32 companies in 2025. Trend: 2023 $2,045 · 2024 $2,219 · 2025 $1,783
Food & beverage: $1,783
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $281 |
| Merck Sharp & Dohme LLC | 6 | $168 |
| Incyte Corporation | 6 | $128 |
| Eisai Inc. | 4 | $110 |
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| Telix Pharmaceuticals | 1 | $100 |
| Celgene Corporation | 4 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| Janssen Biotech, Inc. | 3 | $61 |
| JAZZ PHARMACEUTICALS INC. | 2 | $59 |
Products named: IMFINZI, Lenvima, KEYTRUDA, JAKAFI, ILLUCCIX, SCEMBLIX, Enhertu, LYNPARZA.
Industry payments across MI — which companies pay providers there.
